NantHealth Names Ronald A. Louks as Chief Operating Officer
May 23 2017 - 8:00AM
Business Wire
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation,
evidence-based, personalized healthcare company, today announced
the appointment of Ronald A. Louks as its Chief Operating
Officer.
“Ron brings senior level leadership and excellent experience,
gained at some of the most highly regarded and well recognized
companies in the world, including Blackberry, HTC and Sony
Ericsson,” said Patrick Soon-Shiong, M.D., Chief Executive Officer
and Chairman of NantHealth. “His credentials and experience as an
operations leader who can drive innovation in global organizations
speak for themselves. Ron will oversee the company’s global
operations; he has expertise in launching new products globally,
mergers and acquisitions, supply chain, sales operations,
marketing, manufacturing, e-commerce, retail, quality control,
information technology and growing early stage businesses. We
welcome Ron and he will play an instrumental role to build and
execute our global strategy and drive the company’s growing market
share and international expansion.”
Prior to joining NantHealth, Louks served as President of
Devices & Emerging Solutions at BlackBerry Limited. Earlier,
Louks served as Chief Executive Officer of the OpenNMS Group, the
world’s largest open-source network management company. Before
that, he was Chief Strategy Officer for HTC Corporation, where he
was also responsible for driving new strategic initiatives and all
new technologies including M&A responsibilities. Previous to
this, he held a number of senior leadership positions at Sony
Ericsson, most recently serving as its Chief Technology Officer. He
has driven innovation and launched new products, commercializing
them, and shipped more than 250 million mobile phones globally,
hundreds of millions of accessories, in addition to hundreds of
commercial software products.
About NantHealth, Inc.NantHealth, Inc., a member of the
NantWorks ecosystem of companies, is a next-generation,
evidence-based, personalized healthcare company enabling improved
patient outcomes and more effective treatment decisions for
critical illnesses. NantHealth's unique systems-based approach to
personalized healthcare applies novel diagnostics tailored to the
specific molecular profiles of patient tissues and integrates this
molecular data in a clinical setting with large-scale, real-time
biometric signal and phenotypic data to track patient outcomes and
deliver precision medicine. For nearly a decade, NantHealth has
developed an adaptive learning system, which includes its unique
software, middleware and hardware systems infrastructure that
collects, indexes, analyzes and interprets billions of molecular,
clinical, operational and financial data points derived from novel
and traditional sources, continuously improves decision-making and
further optimizes our clinical pathways and decision algorithms
over time. For more information please
visit www.nanthealth.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170523005661/en/
NantWorksJen Hodsonjohodson@nantworks.com
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Mar 2024 to Apr 2024
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Apr 2023 to Apr 2024